Anika Therapeutics ANIK Q1 2026 Earnings Surprise EPS Beat Amid Revenue Uncertainty GTN Q1 2026 Earnings EPS Misses Estimates as Media Headwinds Persist LMND Q1 2026 Earnings Narrowing Losses Beat Expectations as Underwriting Improves SAM Q1 2026 Earnings EPS Misses Estimates Amidst Persistent Cost Headwinds ENR Q1 2026 Earnings EPS Surges Past Estimates by Over 100 FFWM Q4 2025 Earnings Significant EPS Miss Amidst Challenging Environment FLWS Q1 2026 Earnings Wide EPS Miss Despite Flattish Revenue Environment AKTS Q1 2026 Earnings ClinicalStage Biotech Posts WiderThanExpected Loss Shares Edge Higher KNDI Q2 2024 Earnings Modest Profit Amid Limited Disclosure SHIP Q4 2025 Earnings EPS Surprises to the Upside Amid Robust Dry Bulk Market SAMG Q1 2026 Earnings EPS Misses by 364 as Revenue Details Remain Undisclosed IMMR Q3 2025 Earnings EPS Surges Past Estimates as Haptic Licensing Gains Momentum FuelCell Energy Q1 2026 Earnings EPS Surpasses Estimates Amid Ongoing Operational Challenges